Agreement announced on World Tuberculosis Day revitalises efforts to develop sutezolid as effective response to infectious disease killer
On Friday, March 24 2017, the World...
TB Alliance and the broader TB community are asking the World Health Organisation (WHO) to add Mycobacterium tuberculosis to the critical group within the list of drug-resistant...
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
The Global Alliance for TB Drug Development (TB Alliance) has...